Low-Level Laser (Light) Therapy (LLLT) In Skin: Stimulating, Healing, Restoring
Research Summary
What did early research suggest about low-level light therapy for skin? This 2013 narrative review brings together laboratory experiments and clinical reports on non-thermal laser and LED treatments. The authors discuss skin ageing, acne, pigmentation, scars, burns and inflammatory skin conditions. It is an overview of several research areas, rather than a new trial testing one device or one treatment schedule.
The review describes encouraging findings in some settings, alongside substantial differences in study design and light exposure. It proposes that red and near-infrared light may influence mitochondrial activity and cellular signalling, with possible consequences for inflammation and tissue repair. These biological explanations are hypotheses supported by different experiments; they do not establish that every skin condition or consumer device responds in the same way.
The central practical finding is that treatment parameters matter. Studies used different wavelengths, intensities, exposure times and treatment schedules, sometimes alongside medication or another procedure. The authors acknowledge uncertainty over whether red light, near-infrared light or a combination is preferable for a particular application.
Who Or What Was Studied?
The source is a narrative review covering cultured cells, experimental tissue and animal models, and human clinical studies. It has no single participant count, intervention, comparator or follow-up period. The included evidence ranges from controlled studies to small pilot studies and case reports. The paper does not report a systematic search strategy, a formal risk-of-bias assessment or a pooled treatment-effect estimate.
What Did The Research Show?
- Skin rejuvenation studies reported changes in skin texture, wrinkles and collagen-related measurements. The review also discusses laboratory findings involving fibroblasts, collagen production and enzymes involved in collagen breakdown. These different outcomes should not be treated as a single, established clinical effect.
- For acne, the authors describe studies using red light, blue light or both. Blue light acts through a different proposed pathway involving bacterial porphyrins; red light is discussed in relation to inflammation. Results from combined blue-and-red treatment do not isolate the effect of red light alone.
- One cited acne study used 630 nm light with topical clindamycin and reported a reduction in active lesions, while an 890 nm treatment in the same study did not show a significant effect. This illustrates the importance of protocol and co-treatment; it does not establish a universal wavelength ranking.
- Scar evidence included a report involving three cases with an LED-treated scar compared with a control scar after a procedure. Such a small series can suggest a research direction but cannot provide a reliable estimate of effectiveness for the broader population.
- Pigmentation findings were not uniformly in one direction. The review discusses both repigmentation in vitiligo studies and reduced pigmentation in another setting. Experimental observations about responses to ultraviolet exposure do not establish that light therapy replaces sun protection.
Limitations And Interpretation
This summary is based on the supplied full-text author manuscript, including its references and device table. The article was published in 2013 and describes the evidence available at that time. Its conclusions are not an assessment of the complete current evidence. Several examples involve small samples, uncontrolled observations, mixed treatment protocols or surrogate outcomes. The review's positive descriptions of safety and benefit should be read in that context.
Piri Red interpretation: the paper is useful for understanding why skin photobiomodulation needs condition-specific research and careful reporting of light exposure. It does not demonstrate that a Piri Red product treats acne, psoriasis, vitiligo, scars or burns, and it does not establish a universal home-treatment dose. Laboratory mechanisms and early clinical signals are reasons for further investigation, rather than a guarantee of individual results.
Source
Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, Hamblin MR. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Seminars in Cutaneous Medicine and Surgery. 2013;32(1):41–52. PMID: 24049929. PMCID: PMC4126803.